← Back to Clinical Trials
Recruiting NCT06304389

Effect of Blue Light on Vagus Nerve Stimulation in Patients With Refractory Epilepsy

Trial Parameters

Condition Refractory Epilepsy
Sponsor Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Study Type INTERVENTIONAL
Phase N/A
Enrollment 34
Sex ALL
Min Age 18 Years
Max Age 60 Years
Start Date 2023-07-01
Completion 2023-07-01
Interventions
electroencephalography, electrocardiogram, pupillometry, evoked potentials, light administrationtranscutaneous vagus nerve stimulation, electroencephalography, pupillometry, electrocardiogram, light administration

Brief Summary

Vagus nerve stimulation (VNS) is an adjunctive treatment for refractory epilepsy. Although widely used, there is still a substantial number of patients with insufficient response. Light, and particularly blue light, can stimulate alertness, attention and cognition through modulation of anatomical targets which are common to the vagal afferent network. This project aims at understanding how exposure to blue enriched light may influence VNS effects in patients with refractory epilepsy by exploring the modulation of a series of biomarkers of VNS action. This could possibly lead to new therapeutic strategies to increase efficacy of VNS.

Eligibility Criteria

Inclusion Criteria: Patients: VNS implanted since at least 3 months age \>18-60 years; IQ \>55 on Wechsler scale (normal status or mild cognitive impairment) healthy participants aged between 18 and 35 years without any medical history (neurological / psychiatric disease) Exclusion criteria: Patients: other medical implanted devices than VNS, ocular diseases Helthy participants: medical implanted devices, cerebral trauma, ocular disease

Related Trials